Vanguard Group’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $135M | Sell |
|
|||||
|
2025
Q2 | $93.1M | Buy |
|
|||||
|
2025
Q1 | $114M | Buy |
|
|||||
|
2024
Q4 | $117M | Buy |
|
|||||
|
2024
Q3 | $69M | Buy |
|
|||||
|
2024
Q2 | $54.1M | Buy |
|
|||||
|
2024
Q1 | $66.4M | Buy |
|
|||||
|
2023
Q4 | $32.3M | Buy |
|
|||||
|
2023
Q3 | $27.6M | Buy |
|
|||||
|
2023
Q2 | $22.3M | Buy |
|
|||||
|
2023
Q1 | $15.4M | Buy |
|
|||||
|
2022
Q4 | $17.8M | Buy |
|
|||||
|
2022
Q3 | $16M | Buy |
|
|||||
|
2022
Q2 | $9.57M | Buy |
|
|||||
|
2022
Q1 | $7.72M | Sell |
|
|||||
|
2021
Q4 | $10.3M | Buy |
|
|||||
|
2021
Q3 | $9.24M | Buy |
|
|||||
|
2021
Q2 | $12.3M | Buy |
|
|||||
|
2021
Q1 | $8.8M | Buy |
|
|||||
|
2020
Q4 | $11.2M | Buy |
|